Condition: Nasopharyngeal Carcinoma · Radiotherapy · Chemotherapy · Sponsor: Sun Yat-sen University
Through multicenter, open-label, randomised clinical trials, we intend to demonstrate that radiotherapy with reduced dose could significantly reduce the incidence of radiotherapy toxicities, improve the quality of life of patients while ensuring the tumor control rates for NPC patients staged as II-III who are sensitive to induction chemotherapy (imaging evaluation of CR/PR and EBV DNA copy number decreased to 0 copies/mL after induction chemotherapy)
This description comes directly from the study's public registry record.
Ming-Yuan Chen, MD, PhD · 86-20-87343624 · chmingy@mail.sysu.edu.cn
Rui You, MD, PhD · 86-13580439820 · yourui@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Cancer Center of Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Yuebei People's Hospital | Shaoguan, Guangdong, China | Not Yet Recruiting |
| Zhongshan People's Hospital | Zhongshan, Guangdong, China | Recruiting |
| Wuzhou Red Cross Hospital | Wuzhou, Guangxi, China | Not Yet Recruiting |
| National Cancer Centre Singapore | Singapore, Singapore | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04448522